We are live on !
Find out more
AGM
Alpine Global Management Portfolio holdings
AUM
$615M
Turnover
67.3%
1-Year Est. Return
34.28%
This Fund
S&P 500
This Quarter Est. Return
+30.8%
1 Year Est. Return
+34.28%
3 Year Est. Return
+148.67%
5 Year Est. Return
+161.73%
10 Year Est. Return
+891.97%
AUM
$615M
AUM Growth
-$52.6M
(-7.9%)
Cap. Flow
-$3.04M
Cap. Flow % of AUM
Cap. Flow %
-0.49%
Top 10 Holdings %
Top 10 Hldgs %
62.88%
Holding
367
New
155
Increased
30
Reduced
63
Closed
92
Avg Time Held
Equity + Options
0.4
years
Top 10 Avg Time Held
Equity + Options
1.6
years
Top 20 Avg Time Held
Equity + Options
0.9
years
Avg Time Held Equity only
0.4
years
Top 10 Avg Time Held Equity only
1.6
years
Top 20 Avg Time Held Equity only
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF
XOVR
|
+$47.8M |
| 2 |
SpaceX
SPCX
|
+$43.2M |
| 3 |
Bloom Energy
BE
|
+$33.6M |
| 4 |
Credo Technology Group
CRDO
|
+$26.8M |
| 5 |
Warner Bros
WBD
|
+$8.32M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Immunovant
IMVT
|
+$38.4M |
| 2 |
KKR & Co
KKR
|
+$15M |
| 3 |
Blue Owl Capital
OWL
|
+$14.8M |
| 4 |
Apollo Global Management
APO
|
+$14.7M |
| 5 |
Ares Management
ARES
|
+$14.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 28.03% |
| 2 | Industrials | 21.92% |
| 3 | Technology | 12.25% |
| 4 | Healthcare | 11.36% |
| 5 | Consumer Discretionary | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Immunovant
IMVT
$6.03B
| $53M | 8.61% |
1,375,000
-1,261,925
| -48% | -$38.4M |
2021 Q1
21 quarters
|
|
|
2
EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF
XOVR
$1.41B
| $52.6M | 8.55% |
+2,500,100
| New | +$47.8M |
2026 Q2
0 quarters
|
|
3
Cornerstone Strategic Value Fund
CLM
$1.88B
| $51.7M | 8.4% |
6,833,682
+19,350
| +0.3% | +$146K |
2022 Q2
16 quarters
|
|
4
Rivian
RIVN
$19.4B
| $46.1M | 7.5% |
2,659,651
-1,217
| -0% | -$19K |
2025 Q3
3 quarters
|
|
|
5
SpaceX
SPCX
$1.92T
| $43.4M | 7.06% |
+254,222
| New | +$43.2M |
2026 Q2
0 quarters
|
|
|
6
Bloom Energy
BE
$63.5B
| $39.8M | 6.46% |
+131,336
| New | +$33.6M |
2026 Q2
0 quarters
|
|
|
7
Credo Technology Group
CRDO
$28.4B
| $36.9M | 6% |
+135,658
| New | +$26.8M |
2026 Q2
0 quarters
|
|
8
Archer Aviation
ACHR
$3.23B
| $27.6M | 4.49% |
5,844,879
+213,219
| +4% | +$1.24M |
2024 Q1
9 quarters
|
|
9
Cornerstone Total Return Fund
CRF
$994M
| $21.5M | 3.49% |
2,989,499
+9,387
| +0.3% | +$67.5K |
2022 Q2
16 quarters
|
|
10
State Street SPDR S&P 500 ETF Trust
SPY
$800B
| $14.3M | 2.33% |
19,182
+10,172
| +113% | +$7.37M |
2024 Q3
7 quarters
|
|
|
11
DELISTED
Warner Bros
WBD
| $12.7M | 2.06% |
475,000
+307,500
| +184% | +$8.32M |
2025 Q4
2 quarters
|
|
12
Apollo Commercial Real Estate
ARI
$302M
| $9.6M | 1.57% |
901,968
+734,195
| +438% | +$8M |
2026 Q1
1 quarter
|
|
13
Strategy Inc
MSTR
$57.7B
| $7.5M | 1.22% |
86,266
+1,254
| +1% | +$182K |
2025 Q2
4 quarters
|
|
14
Cohen & Steers Quality Income Realty Fund
RQI
$1.56B
| $6.91M | 1.12% |
+561,401
| New | +$7.28M |
2026 Q2
0 quarters
|
|
15
DELISTED
Liberty Broadband Class A
LBRDA
| $6.57M | 1.07% |
197,551
+2,788
| +1% | +$109K |
2025 Q2
4 quarters
|
|
16
Cisco
CSCO
$409B
| $6.46M | 1.05% |
+54,976
| New | +$5.75M |
2026 Q2
0 quarters
|
|
17
Nextpower Inc. Common Stock
NXT
$14.7B
| $5.61M | 0.91% |
+47,069
| New | +$5.81M |
2026 Q2
0 quarters
|
|
18
QXO Inc
QXO
$12.2B
| $4.32M | 0.7% |
+249,722
| New | +$4.65M |
2026 Q2
0 quarters
|
|
19
DELISTED
Apogee Therapeutics
APGE
| $4.31M | 0.7% |
+32,500
| New | +$2.93M |
2026 Q2
0 quarters
|
|
20
iShares Expanded Tech-Software Sector ETF
IGV
$13.6B
| $3.98M | 0.65% |
+43,974
| New | +$3.91M |
2026 Q2
0 quarters
|
|
21
Brookfield Renewable
BEP
$9.07B
| $3.47M | 0.56% |
+100,000
| New | +$3.47M |
2026 Q2
0 quarters
|
|
22
Intercontinental Exchange
ICE
$95.9B
| $3.44M | 0.56% |
+27,982
| New | +$4.2M |
2026 Q2
0 quarters
|
|
23
Zoom
ZM
$26.9B
| $3.27M | 0.53% |
+37,942
| New | +$3.59M |
2026 Q2
0 quarters
|
|
24
Madrigal Pharmaceuticals
MDGL
$9.47B
| $3.24M | 0.53% |
+6,033
| New | +$3.09M |
2026 Q2
0 quarters
|
|
25
BrightSpire Capital
BRSP
$436M
| $3.22M | 0.52% |
591,653
-305,846
| -34% | -$1.75M |
2023 Q2
12 quarters
|
|
Similar funds
OL
Alpine Global Management's Q2 2026 Portfolio in Review
As of Q2 2026, Alpine Global Management held 367 positions worth $615M, down 7.9% from $668M the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Alpine Global Management's Q2 2026 filing shows 155 new, 30 increased, 63 reduced and 92 closed positions. Its largest new stake was EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF: 2,500,100 shares worth $52.6M. The largest sale was Immunovant, an estimated $38.4M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, down from 30% a quarter earlier, followed by Industrials and Technology.
- Alpine Global Management's largest Q2 2026 buy was EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF: 2,500,100 shares worth $52.6M.
- Alpine Global Management added most to Warner Bros in Q2 2026, an estimated $8.32M increase.
- Alpine Global Management's biggest Q2 2026 reduction was Immunovant, cutting an estimated $38.4M.
- Alpine Global Management fully exited KKR & Co in Q2 2026, selling an estimated $15M.
- Alpine Global Management's ten largest holdings make up 63% of its $615M portfolio in Q2 2026.
- Alpine Global Management opened 155 new positions and closed 92 in Q2 2026.
- Alpine Global Management's portfolio value fell 7.9% quarter-over-quarter to $615M.
Based on Alpine Global Management's 13F filing for Q2 2026, filed 14 Aug 2026.